Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors

AbstractFew studies about the relationship of thyroid stimulating hormone (TSH) level with visceral adiposity index (VAI) and lipid accumulation product (LAP) in large Chinese population are available. The aim of this study was to explore whether TSH level within the reference range was associated with these two newer reliable cardiovascular risk factors. The data were obtained from a cross-sectional study (SPECT-China study, 2014–2015), which was based on the population. Participants underwent several checkups, which included anthropometric parameters, blood pressure, TSH levels, and glucose and lipid profiles. VAI and LAP were calculated. A total of 8727 subjects were enrolled in this study. The mean age was 53.00±13.05 years. Age, female to male ratio, BMI, systolic pressure, and HOMA-IR increased along with the increasing levels of TSH (p<0.01). Analysis of lipid profile showed significantly higher serum triglycerides and LDL cholesterol levels in the higher TSH quartile (p<0.001 and p=0.028, respectively). The levels of VAI and LAP were all increased along with increasing TSH level (all p<0.001). After full adjustment, TSH levels were positively associated with VAI, LAP, and TG/HDL levels significantly (B=0.041, 0.028 and 0.037, respectively, all p<0.01). Higher TSH concentrations among the reference range were common in older people as well as in women subjects, and they were positively associated with VAI and LAP. This highlighted that even subtle variations of serum TSH within the normal range may be potential risk factors for cardiovascular diseases.

Download Full-text

THE ASSESSMENT OF LIFE STYLE AND THE VISCERAL ADIPOSITY INDEX AS CARDIOMETABOLIC RISK FACTORS

Archives of the Balkan Medical Union ◽

10.31688/abmu.2018.53.2.02 ◽

2018 ◽

Vol 53 (2) ◽

pp. 189-195

Author(s):

Sigina R. GÂRGAVU ◽

◽

Diana CLENCIU ◽

Maria M. ROȘU ◽

Tiberiu Ș. ȚENEA COJAN ◽

...

Keyword(s):

Risk Factors ◽

Life Style ◽

Cardiometabolic Risk ◽

Visceral Adiposity ◽

Cardiometabolic Risk Factors ◽

Visceral Adiposity Index ◽

Adiposity Index

Download Full-text

Effect of Exercise Training on Spexin Level, Appetite, Lipid Accumulation Product, Visceral Adiposity Index, and Body Composition in Adults With Type 2 Diabetes

Biological Research For Nursing ◽

10.1177/10998004211050596 ◽

2021 ◽

pp. 109980042110505

Author(s):

Arash Mohammadi ◽

Nahid Bijeh ◽

Mahtab Moazzami ◽

Kazem khodaei ◽

Najmeh Rahimi

Keyword(s):

Type 2 Diabetes ◽

Body Composition ◽

Lipid Accumulation ◽

Visceral Adiposity ◽

Visceral Adiposity Index ◽

Model Assessment ◽

Lipid Accumulation Product ◽

Adiposity Index ◽

Body Strength

Objective To compare the effects of resistance and aerobic training (RT and AT) on spexin (SPX), appetite, lipid accumulation product (LAP), visceral adiposity index (VAI), and body composition in type 2 diabetes mellitus (T2DM) patients. Materials and Methods: Thirty-six T2DM men were randomized to receive RT ( n = 12), AT ( n = 12), or to act as a non-exercise control (CON, n = 12) 3 days a week for 12 weeks. Results: SPX was increased after both RT and AT (66.2% and 46.5%, respectively). VAI, LAP, and homeostasis model assessment-insulin resistance (HOMA-IR) were reduced in both groups, while quantitative insulin sensitivity check index (Quicki) and McAuley’s indexes were increased following both interventions. However, the increases of both hunger and PFC in the RT group were greater than those of the AT. Moreover, the improvement of upper-body strength (41% vs. 10.3%) and lower-body strength (42.2% vs. 20.5%) in the RT group was greater than those of the AT. Conclusion: Our investigation shows that regardless of the modes of the regimen, a 12-week exercise intervention with RT and AT can effectively induce a significant improvement in SPX levels, appetite, LAP, VAI, and body composition in adults with T2DM.

Download Full-text

LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY

Endocrine Practice ◽

10.4158/ep-2017-0007 ◽

2018 ◽

Vol 24 (1) ◽

pp. 33-39 ◽

Cited By ~ 6

Author(s):

Xin Xie ◽

Qing Li ◽

Lingmin Zhang ◽

Wei Ren

Keyword(s):

Cardiometabolic Risk ◽

Cross Sectional Study ◽

Visceral Adiposity ◽

Hormone Deficiency ◽

Visceral Adiposity Index ◽

Sectional Study ◽

Lipid Accumulation Product ◽

Cross Sectional ◽

Adiposity Index ◽

Adult Growth

Download Full-text

Adiposity Indexes as Phenotype-Specific Markers of Preclinical Metabolic Alterations and Cardiovascular Risk in Polycystic Ovary Syndrome: A Cross-Sectional Study

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0042-119524 ◽

2017 ◽

Vol 125 (05) ◽

pp. 307-315 ◽

Cited By ~ 5

Author(s):

Fernanda Mario ◽

Scheila Graff ◽

Poli Spritzer

Keyword(s):

Cardiovascular Risk ◽

Polycystic Ovary Syndrome ◽

Lipid Accumulation ◽

Polycystic Ovary ◽

Visceral Adiposity ◽

Visceral Adiposity Index ◽

Lipid Accumulation Product ◽

Ovary Syndrome ◽

Metabolic Alterations ◽

Adiposity Index

AbstractPolycystic ovary syndrome (PCOS) is a common condition in women of reproductive age. 2 PCOS phenotypes (classic and ovulatory) are currently recognized as the most prevalent, with important differences in terms of cardiometabolic features. We studied the performance of different adiposity indexes to predict preclinical metabolic alterations and cardiovascular risk in 234 women with PCOS (173 with classic and 61 with ovulatory PCOS) and 129 controls. Performance of waist circumference, waist-to-height ratio, conicity index, lipid accumulation product, and visceral adiposity index was assessed based on HOMA-IR ≥ 3.8 as reference standard for screening preclinical metabolic alterations and cardiovascular risk factors in each group. Lipid accumulation product had the best accuracy for classic PCOS, and visceral adiposity index had the best accuracy for ovulatory PCOS. By applying the cutoff point of lipid accumulation product<34, we identified a subgroup of patients without cardiometabolic alterations (P<0.05) in the group with classic PCOS, a population at higher risk for hypertension, dyslipidemia, and impaired glucose tolerance. In ovulatory PCOS, visceral adiposity index ≥ 1.32 was capable of detecting women with significantly higher blood pressure and less favorable glycemic and lipid variables as compared to ovulatory PCOS with lower visceral adiposity index (P<0.05). These results suggest LAP ≥ 34 as the best marker for classic PCOS, and VAI ≥ 1.32 for ovulatory PCOS women. Both indexes can be easily calculated with measures obtained in routine clinical practice and may be useful to detect cardiometabolic risk and secure early interventions.

Download Full-text